TMCnet News

Research and Markets: Global Liver Fibrosis Clinical Trials Report - H2 2013 Review
[December 11, 2013]

Research and Markets: Global Liver Fibrosis Clinical Trials Report - H2 2013 Review


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/gf83km/liver_fibrosis) has announced the addition of the "Liver Fibrosis Global Clinical Trials Review, H2, 2013" report to their offering.

Liver Fibrosis Global Clinical Trials Review, H2, 2013" provides data on the Liver Fibrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Fibrosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the ke drugs for treating Liver Fibrosis.



Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Top Companies Participating in Liver Fibrosis Therapeutics Clinical Trials


  • Merck & Co., Inc.
  • Gilead Sciences, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Pfizer Inc.
  • C. H. Boehringer Sohn AG & Co. KG
  • GlaxoSmithKline plc
  • Gilead Sciences
  • Galectin Therapeutics
  • FibroGen, Inc.
  • CJ Freshway Corporation

Clinical Trial Overview of Top Institutes / Government

  • French National Agency for Research on AIDS and Viral Hepatitis
  • Assistance Publique - Hopitaux de Paris
  • The National Institute of Diabetes and Digestive and Kidney Diseases
  • Imperial College London
  • University of Zurich
  • Beijing Friendship Hospital
  • The National Institute of Allergy and Infectious Diseases
  • China Medical University Hospital
  • Association HGE CHU Bordeaux Sud
  • 302 MILITARY HOSPITAL OF CHINA

For more information visit http://www.researchandmarkets.com/research/gf83km/liver_fibrosis


[ Back To TMCnet.com's Homepage ]